Novogen plans a $39 million IPO of its US subsidiary Glycotex. Jannay Montgomery Scott is acting as underwriter. The company, which is based in Australia and Wilmington, Delaware, is developing drugs designed to enhance wound healing and tissue repair. The company will trade on Nasdaq.
- read this press release for more